Al-Kali, A., Cortes, J., Faderl, S., Jones, D., Abril, C., Pierce, S., . . . Ravandi, F. (2011). Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia.
Citação norma ChicagoAl-Kali, Aref, Jorge Cortes, Stefan Faderl, Dan Jones, Caroline Abril, Sherry Pierce, Mark Brandt, Hagop Kantarjian, and Farhad Ravandi. Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia. 2011.
Citação norma MLAAl-Kali, Aref, et al. Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia. 2011.